You are here

  • Home
  • Archive
  • Volume 93, Issue 10
  • Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease: systematic review and meta-analysis

Article info

Article menu
Neurodegeneration
Original research
Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease: systematic review and meta-analysis

Authors

  • Michael C B David Imperial College London and the University of Surrey, UK Dementia Research Institute Care Research and Technology Centre, London, UK Brain Sciences, Imperial College London, London, UK Imperial College Healthcare NHS Trust, Clinical Neurosciences, Charing Cross Hospital, London, UK PubMed articlesGoogle scholar articles
  • Martina Del Giovane Imperial College London and the University of Surrey, UK Dementia Research Institute Care Research and Technology Centre, London, UK Brain Sciences, Imperial College London, London, UK PubMed articlesGoogle scholar articles
  • Kathy Y Liu Division of Psychiatry, University College London, London, UK PubMed articlesGoogle scholar articles
  • Benjamin Gostick Division of Psychiatry, University College London, London, UK PubMed articlesGoogle scholar articles
  • James Benedict Rowe Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK PubMed articlesGoogle scholar articles
  • Imafidon Oboh South West London and St George’s Mental Health NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Robert Howard Division of Psychiatry, University College London, London, UK PubMed articlesGoogle scholar articles
  • Paresh A Malhotra Imperial College London and the University of Surrey, UK Dementia Research Institute Care Research and Technology Centre, London, UK Brain Sciences, Imperial College London, London, UK Imperial College Healthcare NHS Trust, Clinical Neurosciences, Charing Cross Hospital, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Michael C B David, Imperial College London, London, UK; md2012{at}ic.ac.uk
View Full Text

Citation

David MCB, Del Giovane M, Liu KY, et al
Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease: systematic review and meta-analysis
Journal of Neurology, Neurosurgery & Psychiatry 2022;93:1080-1090.

Publication history

  • Received February 24, 2022
  • Accepted May 19, 2022
  • First published July 5, 2022.
Online issue publication 
September 14, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.